Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IDXX
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
IDXX
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

IDXX Price Prediction Next Week

IDEXX Laboratories (IDXX) Stock Price Prediction and Recommendation

News and Fundamental Analysis:

IDEXX Laboratories reported strong Q4 2024 earnings, with revenue of $954.3 million and EPS of $2.62, exceeding expectations. The company's Companion Animal Group (CAG) drove growth, contributing $870.5 million, a 6% year-over-year increase. IDXX expects organic revenue growth of 6%-9% for fiscal 2025, with EPS projected to grow 10%-15%. Analysts maintain a "Moderate Buy" rating with a mean price target of $518.50, indicating potential upside.

Technical Analysis:

The stock is trading below its 50-day and 200-day moving averages, with an RSI of 44.65, suggesting it may be oversold. The MACD is negative at -6.79, indicating bearish momentum. Fibonacci resistance levels are at $440.47 and $450.58, with support at $407.74 and $397.63.

Price Prediction and Recommendation:

Based on strong earnings and analyst sentiment, IDXX may see a rebound. However, technical indicators suggest caution. The stock is expected to trade between $415 and $435 next week. Given its proximity to support levels and positive fundamentals, a buy recommendation is suggested, targeting resistance levels for potential upside.

IDEXX Laboratories (IDXX) Stock Price Prediction and Recommendation

News and Fundamental Analysis:

IDEXX Laboratories reported strong Q4 2024 earnings, with revenue of $954.3 million and EPS of $2.62, exceeding expectations. The company's Companion Animal Group (CAG) drove growth, contributing $870.5 million, a 6% year-over-year increase. IDXX expects organic revenue growth of 6%-9% for fiscal 2025, with EPS projected to grow 10%-15%. Analysts maintain a "Moderate Buy" rating with a mean price target of $518.50, indicating potential upside.

Technical Analysis:

The stock is trading below its 50-day and 200-day moving averages, with an RSI of 44.65, suggesting it may be oversold. The MACD is negative at -6.79, indicating bearish momentum. Fibonacci resistance levels are at $440.47 and $450.58, with support at $407.74 and $397.63.

Price Prediction and Recommendation:

Based on strong earnings and analyst sentiment, IDXX may see a rebound. However, technical indicators suggest caution. The stock is expected to trade between $415 and $435 next week. Given its proximity to support levels and positive fundamentals, a buy recommendation is suggested, targeting resistance levels for potential upside.

IDXX Similar Chart Price Prediction

The price of IDXX is predicted to go up 5.84%, based on the high correlation periods with ALLK. The similarity of these two price pattern on the periods is 97.68%.

stocks logo

IDXX

stocks logo

ALLK

Up: 5.84%Similarity: 97.68%

IDXX Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

IDXX Price Forecast($)

Potential Return(%)

2025

417.550

-0.120

2026

573.000

31.090

2027

521.000

19.190

2028

750.000

71.580

2029

700.000

60.140

2030

750.000

71.580

What is IDXX stock price prediction 2025 ?

IDXX stock is currently trading at $417.55, with a recent downward trend of -3.31% in regular market trading. Analysts project a 2025 price target range of $435 to $575, with an average of $494.60, driven by moderate revenue growth and expanding oncology diagnostics. However, challenges like declining veterinary visits and macroeconomic pressures may limit upside potential.

What is IDXX stock price prediction 2026 ?

The price prediction for IDXX stock in 2026 is approximately $573 to $580 by mid-year, with potential growth driven by consistent revenue expansion and margin improvements. Analysts expect IDEXX to benefit from its strong position in the veterinary diagnostics market and ongoing innovation in its product offerings. However, macroeconomic factors and market volatility could influence the stock's trajectory.

What is IDXX stock price prediction 2027 ?

IDXX stock is projected to reach approximately $521 by 2027, reflecting a 19% increase from its current price of $437. This growth is supported by consistent revenue expansion, strong performance in the Companion Animal Group, and innovation in diagnostics. However, macroeconomic factors and valuation risks could moderate gains.

What is IDXX stock price prediction 2028 ?

IDXX stock is projected to reach approximately $750 by 2028, driven by consistent revenue growth, margin expansion, and innovation in veterinary diagnostics. The company's historical CAGR of ~10% in revenue and EPS growth supports this trajectory. Additionally, its strong market position and increasing demand for pet healthcare services bolster long-term growth potential.

What is IDXX stock price prediction 2029 ?

IDXX stock is projected to reach approximately $700 by 2029, based on its historical growth trajectory and expected revenue expansion in the veterinary diagnostics sector. This estimate reflects a compound annual growth rate (CAGR) of around 8-10%, supported by strong fundamentals and innovation in its product offerings. However, macroeconomic factors and competitive pressures could influence this forecast.

What is IDXX stock price prediction 2030 ?

IDXX stock is projected to reach approximately $750 by 2030, driven by consistent revenue growth, innovation in veterinary diagnostics, and expanding global market share. The company's strong fundamentals, including a history of double-digit EPS growth and robust operating margins, support this long-term outlook. However, macroeconomic factors and competitive pressures could influence the trajectory.

IDXX Revenue Forecast

IDXX EPS Forecast

IDXX FAQs

What is IDXX revenue forecast for next quarter？

The market consensus for IDXX's revenue in the upcoming quarter is projected to be approximately $1.057B USD.

What is IDXX eps forecast for next quarter？

The market consensus for IDXX's eps in the upcoming quarter is projected to be approximately $3.178 USD.

IDXX VS S&P500

Unlike human healthcare, pet health services and products require cash payments-thereby bypassing the reimbursement issues and pricing pressure associated with third-party payers.

Anecdotal information from vets suggests that Idexx's well-integrated and user-friendly practice management software helps hospitals switch to and stick with Idexx's products and services.

Idexx's sales and customer support staff garner high marks for providing high-touch service to vet practices.

Ask Intellectia about IDXX

IDXX Analyst's Forecast

David Westenberg

Piper Sandler

Hold

2025-02-10

Price Target

$435 → $510

Upside

+13.57%

Piper Sandler raised the firm's price target on Idexx Laboratories to $510 from $435 and keeps a Neutral rating on the shares. The firm cites updated estimates and moving forward of its estimate year to 2026 from 2025.
Daniel Clark

Leerink Partners

Buy

2024-12-02

Price Target

$500

Upside

+15.71%

David Westenberg

Piper Sandler

Hold

2024-11-04

Price Target

$520 → $435

Upside

+4.57%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

BLFS

BioLife Solutions Inc

$23.78
4.16%
stocks logo

MRVI

Maravai LifeSciences Holdings Inc

$2.21
2.31%
stocks logo

TBLA

Taboola.com Ltd

$3.07
2.33%
stocks logo

AMRC

Ameresco Inc

$12.18
1.33%
stocks logo

APOG

Apogee Enterprises Inc

$48
2.78%
stocks logo

ANIP

ANI Pharmaceuticals Inc

$69.36
1.97%
stocks logo

MRC

MRC Global Inc

$11.69
0.60%
stocks logo

EIG

Employers Holdings Inc

$51.04
-0.53%
stocks logo

AMWD

American Woodmark Corp

$60.64
3.76%
stocks logo

DEA

Easterly Government Properties Inc

$10.59
0.19%